Skip to main content
. 2022 Feb 18;12:826655. doi: 10.3389/fonc.2022.826655

Figure 1.

Figure 1

Kaplan–Meyer retrospective analysis of overall survival as a function of replication protein A (RPA) gene expression in non-small cell lung cancer (NSCLC). Blue numbering indicates patients with low RPA expression, red numbering indicates patients with high RPA expression. Analysis represents a 500-patient cohort from the caARRAY, with optimized cutoff. (A) Former and current smokers. HR = 1.63 (1.17–2.28) log-rank: p = 0.0035. (B) Former and current smokers who received chemotherapy. HR = 1.69 (1–2.86) log-rank: p = 0.049. (C) Never smokers.